The Downregulation of miR-22 and miR-372 May Contribute to Gestational Diabetes Mellitus Through Regulating Glucose Metabolism via the PI3K/AKT/GLUT4 Pathway

Researchers highlighted that miR-22 and miR-372 could improve glucose metabolic disorders in gestational diabetes mellitus (GDM) and might serve as diagnostic biomarkers for GDM as well as promising therapeutic targets for the treatment of this condition.